Eisenmenger Syndrome

It is important to understand how the condition develops and affects the heart and lungs before recognising Eisenmenger syndrome symptoms and treatment options.

Eisenmenger syndrome is a long-term complication of an unrepaired congenital heart defect that creates an abnormal connection, or shunt, between the heart chambers or major blood vessels. This defect can cause oxygen-rich blood to flow abnormally from the left side of the circulation to the right side which increases the blood flow to the lungs. The increased blood flow can damage the pulmonary blood vessels and lead to pulmonary vascular remodeling and increased pulmonary vascular resistance, which can cause pulmonary hypertension over time.

As the pressure increases in the pulmonary arteries, the direction of blood flow through the defect may eventually reverse. This can allow oxygen-poor blood to enter the systemic circulation and reach the rest of the body and cause cyanosis, reduced oxygen levels and other complications affecting different organs.

Eisenmenger syndrome is not simply a structural hole in the heart. Once significant pulmonary vascular disease has developed, closing the original defect may be unsafe because the shunt can help to decompress the right-sided circulation. Treatment therefore focuses mainly on controlling symptoms, managing pulmonary hypertension and reducing the risk of complications associated with the condition.

The condition is usually associated with congenital heart defects such as:

Ventricular septal defect is one of the most common congenital heart defects associated with Eisenmenger syndrome.

Understanding Eisenmenger syndrome is only the first step; recognising its symptoms is equally important for timely evaluation and treatment. The symptoms are mainly related to reduced oxygen levels, pulmonary hypertension and the effects of abnormal blood flow.

The severity of Eisenmenger syndrome symptoms may vary depending on the underlying heart defect, the degree of pulmonary hypertension and the person's overall health. Some symptoms may appear over time while others may become more noticeable during physical activity including:

• Shortness of breath: Breathlessness may initially occur during physical activity and can become more persistent as the condition progresses.
• Fatigue: Reduced oxygen delivery to the body's tissues can cause tiredness and reduce the ability to perform daily activities.
• Cyanosis: Reduced oxygen levels in the blood may cause the skin, lips or fingernails to appear blue or grey.
• Dizziness: Low oxygen levels and changes in blood flow may cause dizziness during physical activities.
• Fainting: Some people may experience fainting episodes when the heart is unable to pump enough blood to meet the body's needs.
• Chest discomfort: Chest pain or tightness may occur and can be associated with changes in the heart and pulmonary circulation.
• Clubbing: The fingertips and toenails may become enlarged and rounded over time.
• Headaches: Low oxygen levels and increased red blood cell production may contribute to recurring headaches.
• Palpitations: Irregular, racing or skipped heartbeats may occur because of changes in the heart's structure and rhythm.
• Coughing up blood: Haemoptysis can occur and may require urgent medical evaluation.

The patient should seek immediate medical attention if they have severe breathlessness, chest pain, fainting or significant coughing of blood, as these symptoms may indicate a serious complication.

Understanding the causes of Eisenmenger syndrome can explain how an initially manageable congenital heart defect may eventually lead to permanent changes in the pulmonary blood vessels.

Eisenmenger syndrome usually develops when a congenital heart defect causes a significant left-to-right shunt that remains untreated for a prolonged period.

The increased blood flow towards the lungs gradually raises pressure in the pulmonary arteries. Continued pressure can damage the pulmonary blood vessels and increase pulmonary vascular resistance.

The main congenital heart defects associated with Eisenmenger syndrome include:

• Ventricular Septal Defect: A larger opening between the ventricles can allow substantial blood flow to the lungs and is a common cause of Eisenmenger syndrome.
• Atrial Septal Defect: An opening between the atria can cause abnormal blood flow. Larger defects that remain untreated may contribute to pulmonary vascular disease.
• Patent Ductus Arteriosus: Persistent blood flow through the ductus can increase the amount of blood reaching the lungs.
• Atrioventricular Canal Defect: This condition involves an opening between the heart chambers and may also affect the valves.
• Complex Congenital Heart Defects: More complex structural heart abnormalities can also cause pulmonary hypertension and Eisenmenger physiology.

The risk depends on the type and size of the defect, the amount and duration of abnormal blood flow and whether the congenital heart condition is identified and treated early. Early surgical repair of certain congenital heart defects can generally help prevent the progression to Eisenmenger syndrome.

Eisenmenger syndrome radiology and other diagnostic investigations help doctors assess the heart structure, pulmonary circulation and the effects of reduced blood oxygen levels on different organs. Diagnosis usually requires a combination of medical history, physical examination, imaging and cardiovascular testing.

Diagnosis typically begins with an evaluation of the symptoms and any known congenital heart condition. Doctors may also review previous surgeries, medical reports and family history before selecting the appropriate investigations.

Eisenmenger syndrome imaging may include chest X-ray, CT or MRI depending on the clinical requirement. Cardiac catheterisation can provide important information about pressures and blood flow when the diagnosis or severity requires further assessment.

A walking or exercise test can help doctors to understand how the body responds to physical activity. The clinical findings and diagnostic test results also help doctors to distinguish Eisenmenger syndrome from other causes of pulmonary hypertension and cyanosis.

Once Eisenmenger syndrome has been diagnosed, treatment focuses on managing symptoms, improving quality of life and reducing the risk of complications. Once advanced pulmonary vascular disease has developed, there is no routine surgical procedure that can reverse the changes associated with Eisenmenger syndrome.

The choice of Eisenmenger syndrome treatment depends on the person's symptoms, underlying congenital heart defect, pulmonary pressure, oxygen levels, heart function and other medical conditions.

The main treatment approaches include:

• Pulmonary Vasodilator Medicines: Medicines such as bosentan, sildenafil or tadalafil may be prescribed to reduce pulmonary vascular resistance and improve blood flow through the lungs in suitable patients.
• Heart Rhythm Medicines: Anti-arrhythmic medicines may be used if you have abnormal heart rhythms which require treatment.
• Iron Supplementation: Iron supplements may be prescribed when investigations confirm iron deficiency. However it should not be taken without medical advice because iron levels in blood need appropriate monitoring.
• Blood-Thinning Medicines: Anticoagulants may be considered in selected patients with indications such as certain arrhythmias, previous thromboembolism or mechanical heart valves, but the risks and benefits should be assessed individually because Eisenmenger syndrome can increase the risk of bleeding.
• Phlebotomy: May be considered cautiously when secondary erythrocytosis causes significant hyperviscosity symptoms, particularly when the haematocrit is above 65% and dehydration and iron deficiency have been excluded.
• Transplantation: For selected patients with advanced disease who do not respond adequately to other treatments, heart-lung or lung transplantation may be considered at specialised centres.

Regular follow-up with a cardiologist experienced in adult congenital heart disease is an important part of Eisenmenger syndrome treatment. Medicines should be taken only as prescribed, and any changes in treatment should be discussed with the treating doctor.

The heart and lungs are required to work harder during pregnancy to support the development of the baby. The existing pulmonary hypertension and abnormal blood flow in Eisenmenger syndrome can make it difficult to adapt safely for the cardiovascular system during pregnancy.

Pregnancy with Eisenmenger syndrome carries a very high risk of serious maternal and fetal complications and is generally discouraged. The increased circulatory demands can worsen heart failure, oxygen deficiency, arrhythmias and other complications.

People with Eisenmenger syndrome should discuss pregnancy and contraception with a specialist team before planning a pregnancy. Effective contraception should be discussed with a specialist team because avoiding pregnancy is generally safer for people with established Eisenmenger physiology.

If pregnancy occurs, early consultation with a specialised multidisciplinary team is important. The treatment plan may require careful monitoring of oxygen levels, heart function, pulmonary pressure and medicines because some medicines used for pulmonary hypertension may not be appropriate during pregnancy.

Pregnancy decisions should be based on the individual’s medical condition. A cardiologist and other relevant specialists can explain the potential risks and available options.

The cost of Eisenmenger syndrome treatment in India depends on the severity of the condition, diagnostic requirements, hospital facilities, location, medicines prescribed and whether hospitalisation or advanced procedures are required.

Diagnosis may involve echocardiography, ECG, chest imaging, CT or MRI and, in selected cases, cardiac catheterisation. Cardiac catheterisation costs in India vary considerably across hospitals and procedures; estimates range from around ₹16,000 to ₹150,000, depending on the facility and clinical requirements.

An indicative cost range is given below:

These are indicative estimates and should not be treated as fixed treatment prices. The actual expenses may differ based on the hospital and its location, diagnostic technology, clinical condition, duration of hospitalisation and treatment plan. Long-term medication and follow-up expenses can also increase the overall cost.

Health insurance for Eisenmenger's syndrome may help cover eligible medical expenses. However, coverage depends on the policy terms, medical history, waiting periods, exclusions and underwriting decision.

Health Insurance plans for Eisenmenger's Syndrome may provide financial support for eligible medical expenses, but coverage is not automatically guaranteed for every treatment or every policyholder. Eisenmenger syndrome is associated with a congenital heart defect that may already be known when a person applies for health insurance.

If the condition existed before the policy was purchased and meets the insurer's definition of a pre-existing disease, coverage may be subject to the applicable waiting period, exclusions and other policy conditions. IRDAI states that coverage for disclosed pre-existing diseases is subject to the insurer's underwriting policy and product design, with the applicable waiting period specified in the policy.

The insurance company may also ask you to submit medical records, previous treatment details or medical tests before deciding whether to issue the policy and on what terms. Providing complete and accurate information about existing medical conditions is important because non-disclosure or misrepresentation may affect claim assessment or coverage under the policy terms.

Depending on the policy, eligible expenses may include:

• In-patient Hospitalisation: Expenses related to hospitalisation for medically necessary treatment, subject to the policy terms and conditions.
• Diagnostic Investigations: Eligible tests and investigations may be covered when they are part of an admissible claim and meet policy conditions.
• Pre-hospitalisation Expenses: Certain medical expenses incurred before hospitalisation may be covered for the same condition, subject to the policy limits.
• Post-hospitalisation Expenses: Eligible follow-up medicines, investigations and consultations may be covered for a specified period after discharge.
• ICU Expenses: Intensive care expenses may be covered when emergency medical treatment is required, subject to applicable policy limits.
• Emergency Treatment: Emergency Treatment: Hospital treatment for serious complications may be covered, subject to the policy terms and applicable claim conditions.
• Day Care Treatment: Eligible procedures that meet the insurer's definition of day care treatment may be covered.

Not all regular consultations, medicines or long-term outpatient expenses are necessarily covered under a standard indemnity health insurance policy. The exact benefits depend on the product and its terms.

The outlook for a person with Eisenmenger syndrome can vary considerably. It depends on the underlying congenital heart defect, severity of pulmonary hypertension, oxygen levels, heart function, complications and response to treatment.

Eisenmenger syndrome is a serious long-term condition and may affect several organs because of chronic low oxygen levels and abnormal circulation. Possible complications include arrhythmias, heart failure, bleeding, stroke, kidney problems, infections and other cardiovascular complications.

There is no single life expectancy that applies to everyone with Eisenmenger syndrome. Research has shown substantial variation in survival between patients, and outcomes may differ according to clinical characteristics and the treatment received.

Advances in specialised congenital heart disease and pulmonary hypertension care have improved the management of some patients. Lifelong follow-up, prescribed medicines, avoidance of high-risk situations and timely management of complications remain important for maintaining quality of life.

Eisenmenger syndrome cannot always be prevented because it can develop as a complication of certain congenital heart defects. However, early identification and appropriate treatment of congenital heart disease may prevent or delay the development of severe pulmonary vascular disease.

The following measures may help reduce avoidable risks:

• Early Cardiac Evaluation: Congenital heart defects should be evaluated by an appropriate specialist so that treatment can be considered at the right stage.
• Regular Medical Follow-up: People with congenital heart disease should attend scheduled appointments and undergo recommended tests to monitor heart and lung function.
• Follow the Treatment Plan: Take prescribed medicines regularly and avoid changing doses or stopping them without proper medical guidance.
• Avoid Dehydration: Maintaining adequate hydration may be important because dehydration can affect circulation and may increase health risks in some people with Eisenmenger syndrome, but fluid intake should be guided by the treating doctor when heart failure or fluid retention is present.
• Avoid High Altitudes: Reduced oxygen availability at high altitudes can be problematic for people who already have low blood oxygen levels.
• Avoid Smoking and Second-hand Smoke: Smoking can increase cardiovascular and pulmonary risks and should be avoided.
• Plan Pregnancy Carefully: People with Eisenmenger syndrome should discuss pregnancy risks and suitable contraception with their healthcare team before planning a pregnancy.
• Maintain Medical Records: Keeping reports, prescriptions and previous treatment records organised can help doctors make informed decisions during future consultations.
• Plan for Health Expenses: Reviewing Health Insurance for Eisenmenger's Syndrome early may help in understanding waiting periods, exclusions, network hospitals and eligible treatment expenses.

Disclaimer: The information provided in this article is for general informational and educational purposes only and should not be construed as medical advice, diagnosis, treatment recommendation, or professional healthcare guidance. Treatment costs mentioned are indicative and may vary based on factors such as the patient's medical condition, hospital, city, surgeon's expertise, room category, and other treatment-related requirements.

Readers are advised to consult qualified healthcare professionals and obtain cost estimates directly from healthcare providers before making any medical or financial decisions. Axis Max Life Insurance does not provide medical services, endorse any specific healthcare provider.